Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 95

1.

Prediction of local relapse and distant metastasis in patients with definitive chemoradiotherapy-treated cervical cancer by deep learning from [18F]-fluorodeoxyglucose positron emission tomography/computed tomography.

Shen WC, Chen SW, Wu KC, Hsieh TC, Liang JA, Hung YC, Yeh LS, Chang WC, Lin WC, Yen KY, Kao CH.

Eur Radiol. 2019 May 27. doi: 10.1007/s00330-019-06265-x. [Epub ahead of print]

PMID:
31134366
2.

Textural features of cervical cancers on FDG-PET/CT associate with survival and local relapse in patients treated with definitive chemoradiotherapy.

Chen SW, Shen WC, Hsieh TC, Liang JA, Hung YC, Yeh LS, Chang WC, Lin WC, Yen KY, Kao CH.

Sci Rep. 2018 Aug 8;8(1):11859. doi: 10.1038/s41598-018-30336-6.

3.

Metabolic Imaging Phenotype Using Radiomics of [18F]FDG PET/CT Associated with Genetic Alterations of Colorectal Cancer.

Chen SW, Shen WC, Chen WT, Hsieh TC, Yen KY, Chang JG, Kao CH.

Mol Imaging Biol. 2019 Feb;21(1):183-190. doi: 10.1007/s11307-018-1225-8.

PMID:
29948642
4.

Associations of Tumor PD-1 Ligands, Immunohistochemical Studies, and Textural Features in 18F-FDG PET in Squamous Cell Carcinoma of the Head and Neck.

Chen RY, Lin YC, Shen WC, Hsieh TC, Yen KY, Chen SW, Kao CH.

Sci Rep. 2018 Jan 8;8(1):105. doi: 10.1038/s41598-017-18489-2.

5.

Immunohistochemical biomarkers and volumetric parameters for predicting radiotherapy-based outcomes in patients with p16-negative pharyngeal cancer.

Chen RY, Lin YC, Chen SW, Lin TY, Hsieh TC, Yen KY, Liang JA, Yang SN, Wang YC, Chen YH, Chiang SF, Kao CH.

Oncotarget. 2017 Aug 21;8(42):72342-72351. doi: 10.18632/oncotarget.20374. eCollection 2017 Sep 22.

6.

[18]Fluorodeoxyglucose Positron Emission Tomography for the Textural Features of Cervical Cancer Associated with Lymph Node Metastasis and Histological Type.

Shen WC, Chen SW, Liang JA, Hsieh TC, Yen KY, Kao CH.

Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1721-1731. doi: 10.1007/s00259-017-3697-1. Epub 2017 Apr 14.

PMID:
28409221
7.

Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation.

Lin CY, Liao CW, Chu LY, Yen KY, Jeng LB, Hsu CN, Lin CL, Kao CH.

Clin Nucl Med. 2017 Apr;42(4):e183-e187. doi: 10.1097/RLU.0000000000001545.

PMID:
28114226
8.

Correlation of pretreatment 18F-FDG PET tumor textural features with gene expression in pharyngeal cancer and implications for radiotherapy-based treatment outcomes.

Chen SW, Shen WC, Lin YC, Chen RY, Hsieh TC, Yen KY, Kao CH.

Eur J Nucl Med Mol Imaging. 2017 Apr;44(4):567-580. doi: 10.1007/s00259-016-3580-5. Epub 2016 Dec 20.

PMID:
27999896
9.

Treating hepatocellular carcinoma with 90Y-bearing microspheres: a review.

Hsieh TC, Wu YC, Sun SS, Yen KY, Kao CH.

Biomedicine (Taipei). 2016 Nov;6(4):19. Epub 2016 Nov 16.

10.

Immunohistochemical overexpression of hypoxia-induced factor 1α associated with slow reduction in 18fluoro-2-deoxy-D-glucose uptake for chemoradiotherapy in patients with pharyngeal cancer.

Chen SW, Lin YC, Chen RY, Hsieh TC, Yen KY, Liang JA, Yang SN, Wang YC, Chen YH, Chow NH, Kao CH.

Eur J Nucl Med Mol Imaging. 2016 Dec;43(13):2343-2352. Epub 2016 Jun 16.

PMID:
27311919
11.

Immunohistochemical studies and fluorodeoxyglucose uptake on positron emission tomography in pharyngeal cancer for predicting radiotherapy-based treatment outcomes.

Lin YC, Chen RY, Chen SW, Hsieh TC, Yen KY, Liang JA, Yang SN, Wang YC, Chen YH, Chow NH, Kao CH.

Clin Otolaryngol. 2017 Jun;42(3):608-619. doi: 10.1111/coa.12783. Epub 2016 Nov 14.

PMID:
27762071
12.

Zosteriform Secondary Cutaneous Diffuse Large B-Cell Lymphoma on FDG PET/CT.

Liao CW, Yen KY, Hsieh TC, Kao CH.

Clin Nucl Med. 2016 Sep;41(9):701-2. doi: 10.1097/RLU.0000000000001287.

PMID:
27405036
13.

Incidental Detection of Shoulder Peripheral T-Cell Lymphoma During the Redistribution Phase of 201Tl Myocardial Perfusion Scintigraphy.

Chen YR, Hsieh TC, Yen KY, Kao CH.

Clin Nucl Med. 2015 Oct;40(10):823-5. doi: 10.1097/RLU.0000000000000834.

PMID:
26018700
14.

Risk stratification of metastatic neck nodes by CT and PET in patients with head and neck cancer receiving definitive radiotherapy.

Lin YC, Chen SW, Hsieh TC, Yen KY, Yang SN, Wang YC, Kao CH.

J Nucl Med. 2015 Feb;56(2):183-9. doi: 10.2967/jnumed.114.148023. Epub 2015 Jan 22.

15.

Interim FDG PET/CT for predicting the outcome in patients with head and neck cancer.

Chen SW, Hsieh TC, Yen KY, Yang SN, Wang YC, Chien CR, Liang JA, Kao CH.

Laryngoscope. 2014 Dec;124(12):2732-8. doi: 10.1002/lary.24826. Epub 2014 Jul 10.

PMID:
25042474
16.

Correlation between PET/CT parameters and KRAS expression in colorectal cancer.

Chen SW, Chiang HC, Chen WT, Hsieh TC, Yen KY, Chiang SF, Kao CH.

Clin Nucl Med. 2014 Aug;39(8):685-9. doi: 10.1097/RLU.0000000000000481.

PMID:
24978328
17.

Distant metastases in a young woman with Stewart-Treves syndrome demonstrated by an FDG-PET/CT scan.

Chen YR, Hsieh TC, Yen KY, Kao CH.

Clin Nucl Med. 2014 Nov;39(11):975-6. doi: 10.1097/RLU.0000000000000349.

PMID:
24561687
18.

Correlations between 18F-FDG PET/CT parameters and pathological findings in patients with rectal cancer.

Liao CY, Chen SW, Wu YC, Chen WT, Yen KY, Hsieh TC, Chen PJ, Kao CH.

Clin Nucl Med. 2014 Jan;39(1):e40-5. doi: 10.1097/RLU.0b013e318292f0f6.

PMID:
24335567
19.

Pretreatment metabolic tumor volumes to predict the short-term outcome of unresectable locally advanced squamous cell carcinoma of the esophagus treated with definitive chemoradiotherapy.

Chen SW, Hsieh TC, Ding HJ, Yen KY, Lin CY, Liang JA, Kao CH.

Nucl Med Commun. 2014 Mar;35(3):291-7. doi: 10.1097/MNM.0000000000000046.

PMID:
24276528
20.

Pretreatment (18)F-FDG PET/CT in whole-body total lesion glycolysis to predict survival in patients with pharyngeal cancer treated with definitive radiotherapy.

Chen SW, Hsieh TC, Yen KY, Liang JA, Kao CH.

Clin Nucl Med. 2014 May;39(5):e296-300. doi: 10.1097/RLU.0000000000000243.

PMID:
24217547

Supplemental Content

Support Center